MedTrace Logo

Optical System to Continuously Measure Arterial Blood Pressure

NCT02651558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-04-12

No results posted yet for this study

Summary

Comparison of an optical method to continuously measure blood pressure against an invasive arterial catheter.

Conditions

  • Blood Pressure

Interventions

DEVICE

Experimental: OBPM 2015-MD-0022 - CHEST

At the onset of general anesthesia: 1. continuous measurements of radial arterial blood pressure values (arterial catheter, via a commercial PHILIPS IntelliVue MP50 monitor) 2. continuous estimates of optical blood pressure values at the chest (optical blood pressure system, via Swissmedic approved OBPM measuring device 2015-MD-0022 developed by CSEM) will be recorded.

DEVICE

Experimental: OBPM 2015-MD-0022 - CHEST & FINGER

At the onset of general anesthesia: 1. continuous measurements of radial arterial blood pressure values (arterial catheter, via a commercial PHILIPS IntelliVue MP50 monitor) 2. continuous estimates of optical blood pressure values at the chest (optical blood pressure system, via Swissmedic approved OBPM measuring device 2015-MD-0022 developed by CSEM) 3. continuous estimates of optical blood pressure values at the fingertip (optical blood pressure system, via Swissmedic approved OBPM measuring device 2015-MD-0022 developed by CSEM) will be recorded.

DEVICE

Experimental: OBPM 2015-MD-0022 - FINGER

At the onset of general anesthesia: 1. continuous measurements of radial arterial blood pressure values (arterial catheter, via a commercial PHILIPS IntelliVue MP50 monitor) 2. continuous estimates of optical blood pressure values at the fingertip (optical blood pressure system, via Swissmedic approved OBPM measuring device 2015-MD-0022 developed by CSEM) will be recorded.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER

  • CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement

    lead INDUSTRY

Principal Investigators

  • Patrick Schoettker · CHUV

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-11-01
Completion
2017-11-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651558 on ClinicalTrials.gov